BCPC vs TATE.L
BCPC: Balchem is a leading developer of specialty performance ingredients and solutions for the food, animal health, and pharmaceutical industries, with a strong focus on high-value microencapsulation and specialty chemical technologies. TATE.L: Tate & Lyle is a leading global supplier of specialty food and beverage ingredients focused on sweetness, mouthfeel, and fiber enrichment.
Side-by-side fundamentals
| Metric | BCPC | TATE.L | Edge |
|---|---|---|---|
| Price as of 2026-08-06 close | $180.42 | £5.54 | |
| Market cap as of 2026-08-08 | $5.8B | n/a | |
| P/E as of 2026-08-08 | 34.88 | n/a | |
| PEG as of 2026-08-08 | 2.16 | n/a | |
| Net margin as of 2026-08-08 | +15.1% | n/a | |
| Gross margin as of 2026-08-08 | +36.3% | n/a | |
| Operating margin as of 2026-08-08 | +20.4% | n/a | |
| ROE as of 2026-08-08 | +12.8% | n/a | |
| ROA as of 2026-08-08 | +9.8% | n/a | |
| Debt / equity as of 2026-08-08 | 0.12 | n/a | |
| Revenue growth (YoY) as of 2026-08-08 | +10.1% | n/a | |
| Revenue CAGR (3y) SEC XBRL | +3.2% | n/a | |
| Dividend yield as of 2026-08-08 | +0.5% | n/a | |
| Dividend streak (yrs) SEC XBRL | 4 | n/a | |
| Beta as of 2026-08-08 | 0.86 | n/a | |
| 1-year return as of 2026-08-06 close | +12.8% | +3.2% | BCPC higher |
Fundamentals: market data, as of 2026-08-08. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-06.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.